Effect of Fish Oil on Athlete's Executive Function
NCT04570995 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22
Last updated 2023-03-22
Summary
The goal of this study is to determine the impact of long chain omega-3 PUFA (Polyunsaturated fatty acids) supplementation on executive function in collegiate athletes in a randomized, double-blind, placebo-controlled trial
Conditions
- Brain Health
- Brain Function
- Brain Development
Interventions
- DIETARY_SUPPLEMENT
-
Fish Oil
Dietary supplement containing fish oil, encapsulated in soft gel capsules, given 5 days per week
- DIETARY_SUPPLEMENT
-
Safflower Oil
Dietary supplement containing a placebo oil product (safflower oil), encapsulated in soft gel capsules, given 5 days per week
Sponsors & Collaborators
-
Wake Forest University Health Sciences
lead OTHER
Principal Investigators
-
Elaheh Rahbar, PhD · Wake Forest Health Sciences
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-11-05
- Primary Completion
- 2020-12-18
- Completion
- 2020-12-18
Countries
- United States
Study Locations
More Related Trials
-
Effect of 8-Week Dietary DHA Supplementation on Cerebral Blood Flow and Metabolic Function
NCT00662142 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Feeding Different Levels of Docosahexaenoic Acid to Pre-School Children
NCT01897948 ·Status: TERMINATED ·Phase: NA
-
Fatty Acids and Executive Function Development in 7-12 Year Olds
NCT02199808 ·Status: COMPLETED
-
Essential Fatty Acid (EFA) Nutrition 5-Year-Olds Follow-Up Study
NCT01112904 ·Status: COMPLETED
-
Docosahexaenoic Acid in the Treatment of Autism
NCT00577447 ·Status: COMPLETED ·Phase: NA
-
26 Weeks' Dietary Supplementation With DHA- and EPA-enriched Oils on Cerebral Blood Flow in Healthy Adults
NCT03158545 ·Status: COMPLETED ·Phase: NA
-
The Effect of Supplemental Docosahexaenoic Acid (DHA) on Neurocognitive Outcomes in Teen and Adult Women With Phenylketonuria(PKU)
NCT00892554 ·Status: COMPLETED ·Phase: NA
-
Academic Stress and Proinflammatory Cytokines: Omega-3 Intervention
NCT00519779 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Docosahexaenoic Acid Supplementation on Biomarkers of Concussion Over the Course of a Year in Canadian National Rugby Players
NCT03582267 ·Status: COMPLETED ·Phase: NA
-
The Effects of Efalex Active 50+ on Cognitive Performance, Well-being and Cerebral Hemodynamics in Healthy Older Adults
NCT01185379 ·Status: COMPLETED ·Phase: NA
-
Derivatives of Omega-3 HUFA as Biomarkers of Traumatic Brain Injury
NCT02990091 ·Status: WITHDRAWN ·Phase: PHASE2
-
Omega-3 Treatment for Concussion in Adolescents
NCT05847608 ·Status: UNKNOWN ·Phase: NA
-
Essential Fatty Acid (EFA) Nutrition 5-Year-Olds X Section
NCT01112930 ·Status: COMPLETED
-
The Effects of DHA- and EPA-enriched Oils on Cognitive Function and Mood
NCT02763514 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Fish Oil Supplementation on Cognition in MCI Patients and the Influence of the APOE4 Allele
NCT00746005 ·Status: COMPLETED ·Phase: NA
-
Fish Oil Affects Cognition and ADHD Symptoms in Adults With Autism Spectrum Disorder
NCT04779632 ·Status: COMPLETED ·Phase: NA
-
The Effects of EPA/DHA Supplementation on Cognitive Control in Children With ADHD
NCT01554462 ·Status: COMPLETED ·Phase: NA
-
The Efficacy of Omega-3 Fatty Acids in Maintaining Optimal Mental Health in Elderly People
NCT00124852 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial of the Effects of DHA in the Treatment of Seizure Disorders
NCT01769092 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Preliminary Study of Fish Oil and Dementia
NCT00628017 ·Status: COMPLETED ·Phase: NA
-
Effects of Docosahexaenoic Acid (DHA) on Cognitive Function in Children 4 Years of Age
NCT00351624 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Long Chain Polyunsaturated Fatty Acids on Behavior and Cognition in Children With Attention Deficit Hyperactivity Disorder
NCT01055119 ·Status: COMPLETED ·Phase: NA
-
DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease
NCT00440050 ·Status: COMPLETED ·Phase: PHASE3
-
Behavioral, Genetic, and Epigenetic Implications of Dietary Supplementation With Alpha-linolenic Acid in Humans
NCT01634776 ·Status: COMPLETED ·Phase: NA
-
Effects of Docosahexaenoic Acid (DHA)-Rich Fish Oil on Cerebral Haemodynamics
NCT01075932 ·Status: COMPLETED ·Phase: NA